NEW YORK, Dec. 12 — Berlin’s Max Delbruck Center for Molecular Medicine bought a high-throughput genotyping system from Pyrosequencing, the company announced today.
The Berlin institution’s Gene Mapping Center and Department of Molecular Genetics will use Pyrosequencing’s Preferred Technology Program for SNP analysis in research into the genetics of complex diseases. Researchers will also collaborate with Pyrosequencing to continue to develop and expand the capacity of the system.
Pyrosequencing’s automated PTP system, with 384-well microplates, can score up to 100,000 SNPs per day, according to the company. The product, which was introduced earlier this year, sells for $350,000 but can go for more than $1 million with additional robotics, a spokeswoman said.
“We explored a number of SNP technologies but chose PTP because we have had impressive results with Pyrosequencing’s PSQ 96 System. Our need to analyze more samples is increasing, and PTP offers a more cost-effective solution based on the same technology,” said GMC head Peter Nurnberg in a statement. The Gene Mapping Center is a specialized lab for high-throughput genotyping for monogenic and complex diseases. Projects include studies for genes involved in cancer, high blood pressure, lipid metabolism disorders and brain tumors. Next year, the center plans to double its current annual capacity of approximately 2 million high-quality STR genotypes.